Curis
CRIS
#10633
Rank
S$16.17 M
Marketcap
S$0.42
Share price
55.98%
Change (1 day)
-85.00%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.75. In 2024 the company made an earnings per share (EPS) of S-$9.09 an increase over its 2023 EPS that were of S-$11.68.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-46.38%
2024S-$9.09-22.15%
2023S-$11.68-26.17%
2022S-$15.8122.3%
2021S-$12.93-25.37%
2020S-$17.33-30.93%
2019S-$25.09-2.02%
2018S-$25.60
2016S-$58.19-10%
2015S-$64.65138.1%
2014S-$27.1640%
2013S-$19.40-25%
2012S-$25.8666.67%
2011S-$15.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.69-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.60-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.47-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.05-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.03 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.53 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.82-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA